Bridge Anticoagulant: A Hitherto Unrecognized Blood Clotting Inhibitor in Haemophilic and Christmas‐Disease Plasma. A Simple Method for its Demonstration
- 1 January 1958
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 4 (1) , 38-50
- https://doi.org/10.1111/j.1365-2141.1958.tb03832.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- THE INFLUENCE OF BLOOD-CLOTTING FACTORS ON THE ULTRAVIOLET ABSORPTION AND SPECIES SPECIFICITY OF PLASMA THROMBOPLASTINQuarterly Journal of Experimental Physiology and Cognate Medical Sciences, 1957
- BOVINE ANTIHÆMOPHILIC GLOBULIN IN THE TREATMENT OF HÆMOPHILIAThe Lancet, 1954
- The initial stages of blood coagulationThe Journal of Physiology, 1953
- The Thromboplastin Generation TestJournal of Clinical Pathology, 1953
- The formation of thromboplastin in human bloodThe Journal of Physiology, 1953
- Plasma Throinboplastin Component (PTC) Deficiency: A New Disease Resembling HemophiliaExperimental Biology and Medicine, 1952
- Clotting Defect in Hemophilia: Deficiency in a Plasma Factor Required for Platelet UtilizationExperimental Biology and Medicine, 1947
- HEMOPHILIA: THE CLINICAL USE OF ANTIHEMOPHILIC GLOBULINAnnals of Internal Medicine, 1947
- Glyoxalines: the determination of their pK values and the use of their salts as buffersBiochemical Journal, 1938
- The pathogenesis of hereditary hæmophiliaThe Journal of Pathology and Bacteriology, 1911